• Corpus ID: 214641793


  author={Jammie K. Barnes and Maureen D. Mayes},
Recent findings SSc disease occurrence data are now available for Argentina, Taiwan, and India and continue to show wide variation across geographic regions. The survival rate is negatively impacted by older age of onset, male sex, scleroderma renal crisis, pulmonary fibrosis, pulmonary arterial hypertension, cancer, and antitopoisomerase and anti-U1 antibodies. It appears that silica exposure confers an increased risk for developing scleroderma, but this exposure accounts for a very small… 

Tables from this paper

Clinical and laboratory features of African-Brazilian patients with systemic sclerosis

African-Brazilians have distinct characteristics according to clinical subset and an overall more severe SSc than whites, similar to the blacks from other countries.

Diffuse Systemic Sclerosis : Evolution in Treatment

It is emphasized that there are still unmet needs to achieve effective treatment in diffuse SSc and to reach this goal more studies need to be conducted.

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.

Among patients with early diffuse cutaneous systemic sclerosis, HSCT was associated with increased treatment-related mortality in the first year after treatment, however, HCST conferred a significant long-term event-free survival benefit.

Prevalence of rheumatic diseases in a rheumatology outpatient practice of a tertiary hospital

Dgenerative conditions (osteoarthritis and spondylosis) and soft tissue rheumatism were the most common rheumatology diagnoses in new patients, while osteoarth arthritis and rhearatoid arthritis were most prevalent in followup patients.



A study of the prevalence of systemic sclerosis in northeast England.

SSc appears to be more common in northeast England than was found in the West Midlands in 1986, and may reflect changes in the diagnostic definition of SSc.

Incidence and Prevalence of Systemic Sclerosis in a Healthcare Plan in Buenos Aires

Examination of the incidence and prevalence of systemic sclerosis in the prepaid health maintenance organization of a hospital in Buenos Aires finds data are in agreement with others from different parts of the world and the first obtained in Argentina and, to the authors' knowledge, in Latin America.

Late-age Onset Systemic Sclerosis

Older patients with SSc are at greater risk for pulmonary hypertension, renal impairment, cardiac disease, and muscle weakness, and awareness of the distinct risk for specific organ manifestations in SSc should guide the care of patients whose disease begins after age 65.

HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis.

The results of this study suggest that DRB1*0407 and *1304 are independent risk factors, beyond the known clinical correlates, for the development of SRC.

Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype.

A major risk factor for disease is a uniquely Amerindian HLA haplotype; however, additional genes and/or an as-yet-unidentified environmental exposure seem likely.

Systemic Sclerosis in Northwestern Spain: A 19-year Epidemiologic Study

The results, the incidence and prevalence of SSc in northwestern Spain are similar to those found in Greece and some regions of the United States, and a reduced probability of survival in patients with SSc is confirmed.

Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.

This study establishes baseline estimates of SSc occurrence and characteristics in a large US cohort consisting primarily of black adults and white adults to facilitate research regarding the role of geographic, ethnic, racial, and environmental factors for this disease in comparison populations.

Malignancy in scleroderma patients from south west England: a population-based cohort study

It is found that scleroderma is associated with an increased risk of malignancy and this risk is statistically significant in patients with limited sclerodma, which should be closely scrutinized at follow-up appointments.

Prevalence of scleroderma spectrum disorders in the general population of South Carolina.

The results suggest that the prevalence of scleroderma spectrum disorders may range from 67 to 265 per 100,000, which is 4.9 to 19.2 times higher than previously reported for definite SSc.

An epidemiological study of scleroderma in the West Midlands.

This first epidemiological study of the occurrence of scleroderma in the UK suggests prevalence rates of 13 and 48 per million in males and females respectively, with annual incidence rates of 1 and 6 per million.